Electromed stock leaps as FDA approves new product

Electromed stock leaps as FDA approves new product

The FDA approval could help Electromed turn a corner after it earlier this year reported its first loss since going public in 2010. The company lost $1.3 million on revenue of $15.1 million in the fiscal year that ended in June. It earned $187,000 on

2
Like
Save

Comments

Write a comment

*